Responsiveness of the Object Permanence Scale
Launched by TOKAT GAZIOSMANPASA UNIVERSITY · Feb 19, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how babies with motor developmental delays respond to the Object Permanence Scale, which helps us understand how infants perceive objects in their environment. Researchers are looking for babies aged 7 to 16 months who can sit up for at least 3 seconds but have difficulty moving between sitting and other positions. These babies must also show some delays in their motor skills based on a specific assessment called the Bayley III.
If your baby meets these criteria, they could be eligible to participate in the trial. Participants will be evaluated at the start of the study and again after three months to see how they progress. It’s important to note that babies with certain medical conditions, such as severe vision problems, autism, Down syndrome, or uncontrolled seizure disorders, will not be included in this study. This trial is currently recruiting participants, and it aims to gain insights that could help improve support for babies with developmental delays.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 7-16 months,
- • Sitting for at least 3 seconds but unable to independently switch between sitting and other positions
- • To show at least one retardation in motor subscale of Bayley III.
- Exclusion Criteria:
- • Medical complications (eg, severe visual impairment) limiting participation in assessments; autism, down syndrome, or spinal cord injury; diagnosed uncontrolled seizure disorder; or a neurodegenerative disorder
About Tokat Gaziosmanpasa University
Tokat Gaziosmanpasa University is a distinguished academic institution dedicated to advancing medical research and innovation through rigorous clinical trials. With a commitment to enhancing healthcare outcomes, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct comprehensive studies that address critical health challenges. By fostering collaboration among researchers, healthcare professionals, and industry partners, Tokat Gaziosmanpasa University aims to contribute valuable insights to the scientific community and improve patient care through evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tokat, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials